title: Contribution of intracellular Ca2+ concentration and protein dephosphorylation to the induction of dopamine release from PC12 cells by the green odor compound hexanal.
abstract: n-Hexanal (hexanal), a straight-chain six-carbon aldehyde, is mainly present in plants. Hexanal strongly affects the release of dopamine from rat striatal slices and rat pheochromocytoma (PC12) cells. In this study, we attempted to clarify the mechanism underlying the regulation of dopamine release by hexanal by using PC12 cells, which have the ability to synthesize, store, and release dopamine. The stimulation of PC12 cells with hexanal enhanced dopamine release in a time- and dose-dependent manner. Dopamine release was partially inhibited by pretreatment of the cells with BAPTA-AM, a cell-permeable Ca2+ chelator. In addition, the intracellular Ca2+ concentration was found to slowly increase after hexanal stimulation. Furthermore, the Src tyrosine kinase inhibitor PP2 partially inhibited hexanal-induced dopamine release. However, the levels of phosphorylated proteins decreased after hexanal stimulation. Hexanal stimulated the release of only a small amount of dopamine from reserpine-treated PC12 cells, in which the vesicular dopamine was depleted. These findings suggest that both an increase in the intracellular Ca2+ concentration and the dephosphorylation of phosphorylated proteins might be required for hexanal-stimulated release of dopamine, and that the dopamine released because of hexanal stimulation mainly comes from the dopamine vesicles. This study showed the cellular events that occurred in PC12 cells after stimulation of hexanal. Furthermore, it is important to examine the relationship between the cellular functions and the physiological effects of hexanal on dopamine release.
authors.affiliation: Laboratory of Nutritional Biochemistry and Global COE (Center of Excellence) Program, Graduate School of Nutritional and Environmental Sciences, University of Shizuoka, Yada 52-1, Suruga-ku, Shizuoka, Shizuoka, 422-8526, Japan. kobayashi-yo@kiryu-u.ac.jp
authors.forename: Yoko
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: Hironari
authors.initials: H
authors.lastname: Kako
authors.forename: Hidehiko
authors.initials: H
authors.lastname: Yokogoshi
mesh_terms: D000447:Aldehydes / Q000494:pharmacology*; D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology; D002118:Calcium / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism*; D009812:Odorants; D016716:PC12 Cells / Q000187:drug effects / Q000378:metabolism; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000378:metabolism; D051381:Rats; D017208:Rats, Wistar
chemical_list: D000447:Aldehydes; D000935:Antifungal Agents; C010463:n-hexanal; D011505:Protein-Tyrosine Kinases; D002118:Calcium; D004298:Dopamine
references.citation: Biosci Biotechnol Biochem. 1999 Apr;63(4):743-8
references.pmid: 10361687
references.citation: Proc Natl Acad Sci U S A. 1976 Jul;73(7):2424-8
references.pmid: 1065897
references.citation: Br J Pharmacol. 1996 May;118(2):378-84
references.pmid: 8735641
references.citation: Brain Res. 1984 Feb 20;293(2):251-8
references.pmid: 6607764
references.citation: J Pharmacol Exp Ther. 2001 Jun;297(3):1016-24
references.pmid: 11356924
references.citation: J Cell Biol. 1984 Aug;99(2):628-38
references.pmid: 6204995
references.citation: Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10930-5
references.pmid: 11535829
references.citation: J Pharmacol Exp Ther. 1994 Jul;270(1):336-41
references.pmid: 8035329
references.citation: Neuropharmacology. 1983 Mar;22(3 Spec No):441-6
references.pmid: 6304562
references.citation: J Neurochem. 2000 Jun;74(6):2296-304
references.pmid: 10820189
references.citation: Brain Res Mol Brain Res. 2003 Feb 20;110(2):159-68
references.pmid: 12591153
references.citation: Proc Natl Acad Sci U S A. 1995 Mar 28;92(7):2825-9
references.pmid: 7708732
references.citation: FASEB J. 2008 May;22(5):1416-25
references.pmid: 18096815
references.citation: Neurosci Res. 2004 Mar;48(3):259-67
references.pmid: 15154672
references.citation: J Biochem. 2001 Nov;130(5):703-9
references.pmid: 11686934
references.citation: Brain Res. 1997 Dec 19;778(2):309-17
references.pmid: 9459548
references.citation: Oncogene. 1993 Dec;8(12):3343-51
references.pmid: 8247536
references.citation: J Neurosci. 1985 May;5(5):1176-9
references.pmid: 2987434
references.citation: Brain Res. 1985 Dec 16;359(1-2):97-103
references.pmid: 4075164
references.citation: Br J Pharmacol. 2001 Jul;133(5):651-8
references.pmid: 11429388
references.citation: Brain Res. 1977 Jul 1;129(2):247-63
references.pmid: 560237
references.citation: Biochem Biophys Res Commun. 1998 Jan 26;242(3):669-72
references.pmid: 9464275
references.citation: Metabolism. 2003 Jul;52(7):922-6
references.pmid: 12870171
references.citation: Science. 1997 Oct 24;278(5338):698-701
references.pmid: 9381182
references.citation: Physiol Behav. 2004 Jan;80(4):481-8
references.pmid: 14741233
references.citation: Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4761-5
references.pmid: 9114065
references.citation: Brain Res. 2007 Jan 19;1129(1):174-90
references.pmid: 17157274
references.citation: Physiol Behav. 2002 Mar;75(3):355-60
references.pmid: 11897262
references.citation: J Physiol. 1979 Jan;286:541-61
references.pmid: 571467
references.citation: Brain Res Bull. 2008 Mar 28;75(5):706-12
references.pmid: 18355650
references.citation: Ann N Y Acad Sci. 2002 Oct;971:366-70
references.pmid: 12438154